179 related articles for article (PubMed ID: 31533820)
1. Fluorescence optical imaging for treatment monitoring in patients with early and active rheumatoid arthritis in a 1-year follow-up period.
Glimm AM; Sprenger LI; Haugen IK; Mansmann U; Hermann S; Häupl T; Hoff P; Burmester GR; Backhaus M; Le L; Ohrndorf S
Arthritis Res Ther; 2019 Sep; 21(1):209. PubMed ID: 31533820
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of patients with rheumatoid arthritis by indocyanine green (ICG)-enhanced fluorescence optical imaging treated with anti-TNFα therapy.
Hertrampf S; Klotsche J; Schefer Q; Glimm AM; Burmester GR; Hoff P; Schmittat G; Häupl T; Hermann S; Backhaus M; Ohrndorf S
Arthritis Res Ther; 2022 May; 24(1):117. PubMed ID: 35596202
[TBL] [Abstract][Full Text] [Related]
3. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
[TBL] [Abstract][Full Text] [Related]
4. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
El Miedany Y; Youssef SS; El Gaafary M
J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
[TBL] [Abstract][Full Text] [Related]
5. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
Pease C; Pope JE; Truong D; Bombardier C; Widdifield J; Thorne JC; Paul Haraoui B; Psaradellis E; Sampalis J; Bonner A
Semin Arthritis Rheum; 2011 Aug; 41(1):81-9. PubMed ID: 21168187
[TBL] [Abstract][Full Text] [Related]
6. Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
Bakker MF; Jacobs JW; Kruize AA; van der Veen MJ; van Booma-Frankfort C; Vreugdenhil SA; Bijlsma JW; Lafeber FP; Welsing PM
Ann Rheum Dis; 2012 Jun; 71(6):830-5. PubMed ID: 22128075
[TBL] [Abstract][Full Text] [Related]
7. A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritis.
Inderjeeth CA; Inderjeeth AJ; Raymond WD
Int J Rheum Dis; 2019 Jan; 22(1):73-80. PubMed ID: 30187688
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared Fluorescence Optical Imaging in Early Rheumatoid Arthritis: A Comparison to Magnetic Resonance Imaging and Ultrasonography.
Krohn M; Ohrndorf S; Werner SG; Schicke B; Burmester GR; Hamm B; Backhaus M; Hermann KG
J Rheumatol; 2015 Jul; 42(7):1112-8. PubMed ID: 25934821
[TBL] [Abstract][Full Text] [Related]
9. A novel fluorescence optical imaging scoring system for hand synovitis in rheumatoid arthritis-validity and agreement with ultrasound.
Ammitzbøll-Danielsen M; Glinatsi D; Terslev L; Østergaard M
Rheumatology (Oxford); 2022 Feb; 61(2):636-647. PubMed ID: 33890623
[TBL] [Abstract][Full Text] [Related]
10. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
[TBL] [Abstract][Full Text] [Related]
11. Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.
Weinblatt ME; Fleischmann R; van Vollenhoven RF; Emery P; Huizinga TW; Cutolo M; van der Heijde D; Duncan B; Davies O; Luijtens K; Dougados M
Arthritis Res Ther; 2015 Nov; 17():325. PubMed ID: 26568428
[TBL] [Abstract][Full Text] [Related]
12. Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis.
Mäkinen H; Kautiainen H; Hannonen P; Möttönen T; Korpela M; Leirisalo-Repo M; Luukkainen R; Puolakka K; Karjalainen A; Sokka T
J Rheumatol; 2007 Oct; 34(10):1987-91. PubMed ID: 17611990
[TBL] [Abstract][Full Text] [Related]
13. Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort.
Sewerin P; Vordenbaeumen S; Hoyer A; Brinks R; Buchbender C; Miese F; Schleich C; Klein S; Schneider M; Ostendorf B
BMC Musculoskelet Disord; 2017 Apr; 18(1):163. PubMed ID: 28420375
[TBL] [Abstract][Full Text] [Related]
14. Elevated DAS28-ESR in patients with rheumatoid arthritis who have comorbid fibromyalgia is associated more with tender joint counts than with patient global assessment or swollen joint counts: implications for assessment of inflammatory activity.
Kannayiram S; Schmukler J; Li T; Goodson N; Sridhar A; Pincus T
Clin Exp Rheumatol; 2024 May; 42(5):1083-1090. PubMed ID: 38525998
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytokine profiles in rheumatoid arthritis patients with clinically active disease and normal inflammatory indices.
Alex AM; Sayles H; Mikuls TR; Kerr GS
Clin Rheumatol; 2019 Apr; 38(4):1075-1081. PubMed ID: 30506404
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group level.
Riazzoli J; Nilsson JÅ; Teleman A; Petersson IF; Rantapää-Dahlqvist S; Jacobsson LT; van Vollenhoven RF
Rheumatology (Oxford); 2010 Nov; 49(11):2098-103. PubMed ID: 20615918
[TBL] [Abstract][Full Text] [Related]
17. Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
Choi S; Lee KH
PLoS One; 2018; 13(4):e0195550. PubMed ID: 29624625
[TBL] [Abstract][Full Text] [Related]
18. Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography.
Janta I; Naredo E; Martínez-Estupiñán L; Nieto JC; De la Torre I; Valor L; Estopiñán L; Bello N; Hinojosa M; González CM; López-Longo J; Monteagudo I; Montoro M; Carreño L
Rheumatology (Oxford); 2013 Dec; 52(12):2243-50. PubMed ID: 24046468
[TBL] [Abstract][Full Text] [Related]
19. Tender Joint Count and Inflammatory Activity in Patients With Established Rheumatoid Arthritis: Results From a Longitudinal Study.
Hammer HB; Michelsen B; Provan SA; Sexton J; Lampa J; Uhlig T; Kvien TK
Arthritis Care Res (Hoboken); 2020 Jan; 72(1):27-35. PubMed ID: 30474932
[TBL] [Abstract][Full Text] [Related]
20. Contribution of subjective Disease Activity Score 28 (DAS28) components to the response to treatment of rheumatoid arthritis.
Son KM; Lee SY; Seo YI; Choi JE; Kim HA
Clin Rheumatol; 2017 Jun; 36(6):1221-1227. PubMed ID: 28451869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
